Hany Massarany, President and CEO at GenMark Diagnostics, Inc. (GNMK), sold 32,846 shares at $5.43 ($178K) on 2019-11-25, disclosed to the SEC on 2019-11-26.
Seasonal sale ($178k) by President and CEO — this insider has traded GNMK in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.43 | 16,423 | $89K | 50.0% |
| 2 | $5.43 | 16,423 | $89K | 50.0% |
| Total | $5.43 avg | 32,846 | $178K | 100% |
| Filing → |
| AXDX | BUY | 2022-02-01 | $66K | — | Filing → |
| AXDX | BUY | 2021-09-28 | $53K | — | Filing → |
| BDSX | BUY | 2020-11-03 | $135K | — | Filing → |